Glucocorticoids are known to influence many aspects of prenatal development. Three important regulators of glucocorticoid actions at the cellular level are the enzymes 11␤-hydroxysteroid dehydrogenase type 1 (11␤HSD-1), 11␤-hydroxysteroid dehydrogenase type 2 (11␤HSD-2), and glucocorticoid receptors (GR). The present study was conducted to determine the presence of these regulators in porcine placentae during early gestation (Days 24-40; term ‫؍‬ 114 days) and to examine the influence of breed and uterine environment. Three pig models differing in uterine environment as reflected by embryonic survival from Days 24 to 40 were used: intact white cross-bred gilts (WC-INT); white cross-bred gilts that had been unilaterally hysterectomized-ovariectomized before puberty (WC-UHO); and intact Meishan gilts (ME). Porcine-specific partial cDNAs for 11␤HSD-1 and 11␤HSD-2 and a cRNA for GR␣ were developed and used to produce 32 P-labeled probes for Northern blot analyses. The 11␤HSD dehydrogenase activity was measured in vitro at saturating concentrations of substrate and coenzyme. At Day 24 of gestation, 11␤HSD-2 mRNA, dehydrogenase activity, and GR mRNA were present, but 11␤HSD-1 mRNA was absent. All three mRNAs and dehydrogenase activity increased (P Ͻ 0.01) by Day 40. On Day 30, placental 11␤HSD-2 mRNA was decreased (P ‫؍‬ 0.03) by 47% in WC-UHO versus WC-INT. Placental 11␤HSD dehydrogenase activity was 2-fold greater (P Ͻ 0.01) in ME versus WC-INT on Day 24 of gestation. These results demonstrate, to our knowledge for the first time, the presence of 11␤HSD-1, 11␤HSD-2, and GR mRNA as well as 11␤HSD dehydrogenase activity in the porcine placenta during early pregnancy. Moreover, a role for glucocorticoids in porcine embryonic development is suggested. conceptus, cortisol, developmental biology, embryo, glucocorticoid receptor
INTRODUCTION
Multiple mechanisms exist for regulating cellular actions of glucocorticoids such as cortisol. One such mechanism is 1 Mention of trade names is necessary to report factually on available data; however, the USDA neither guarantees nor warrants the standard of the product, and the use of the name by USDA implies no approval of the product to the exclusion of others that may also be suitable.
the enzyme 11␤-hydroxysteroid dehydrogenase (11␤HSD) that reversibly converts biologically active cortisol to inactive cortisone. Two predominant 11␤HSD isoforms exist: 11␤HSD type 1 (11␤HSD-1), which has both dehydrogenase and oxoreductase activities and uses NADP ϩ and NADPH, respectively, as coenzymes [1, 2] but usually acts as a reductase enzyme [3, 4] , and 11␤HSD type 2 (11␤HSD-2), which has only dehydrogenase activity and uses NAD ϩ as a coenzyme [5] . Previous work revealed placental 11␤HSD activity in numerous species (e.g., [6] [7] [8] [9] [10] ). We demonstrated with pigs that maternal cortisol was converted to cortisone as it traverses the porcine placenta, and indeed, maternal cortisol provided 50% of fetal cortisone during mid and late gestation [11] . We subsequently showed that this placental cortisol conversion to cortisone resulted from the presence of NAD ϩ -and NADP ϩ -dependent 11␤HSD dehydrogenase activities [12] . We also used placental tissue fragment cultures with endogenous levels of substrates and coenzymes to show the following at 75 days of gestation: 1) both 11␤HSD oxoreductase and dehydrogenase activities were present, 2) dehydrogenase activity was 5-fold greater than oxoreductase activity, and 3) significant positive linear associations were present between net dehydrogenase activity and fetal or placental size [13] .
A second cellular mechanism that regulates biological effects of glucocorticoids is the glucocorticoid receptor (GR). In humans, the GR consists of two protein isoforms, GR␣ and GR␤, with GR␣ being the biologically relevant isoform [14, 15] . The GR␤ isoform is unable to bind glucocorticoid hormones but may form heterodimers with GR␣, thereby altering the ability of GR␣ to regulate transcription [14, 15] . Thus, although the presence of cortisol in porcine embryos as early as Day 24 of gestation [16] suggests that cortisol may influence early embryonic development, this is necessary-but not sufficient-evidence that cortisol is active. The GRs must also be present within embryonic and placental target tissues for cortisol to exert its effects.
Therefore, to provide further suggestive evidence for an action of glucocorticoids on both porcine placental development and function and embryonic development, the objectives of the present study were as follows: 1) to determine if placental 11␤HSD-1 and 11␤HSD-2 mRNA expression and dehydrogenase activity are present in porcine placentae during early gestation (Days 24, 30, and 40); 2) to determine if this 11␤HSD expression is influenced by breed and uterine environment; and 3) to determine if mRNA expression of GR is present in embryonic placentae at these gestational ages. Because glucocorticoids are known to influence placental and fetal size as well as fetal survival in other species (e.g., [17, 18] ), it was considered to be of interest to determine if these cellular mechanisms regulating cortisol actions might be altered by breed or uterine environments associated with altered fetal size and survival.
MATERIALS AND METHODS

Animals, Experimental Design, and Tissue Collections
White crossbred (WC) gilts remained intact (INT; n ϭ 17) or were unilaterally hysterectomized and ovariectomized (UHO; n ϭ 18) at 160 days of age as previously described [19] . Chinese Meishan gilts (ME; n ϭ 18), which are known for their increased litter size [20] , remained intact. Gilts were randomly assigned to be sampled at Day 24, 30, or 40 of gestation and were bred as previously described for this study [21] . On the appropriate day of gestation, gilts were slaughtered in the U.S. Department of Agriculture Meat Animal Research Center abattoir. Reproductive tracts were removed immediately, and placental samples were obtained as rapidly as possible. Tissue was rapidly frozen in liquid nitrogen and stored frozen at Ϫ80ЊC until used for 11␤HSD and GR analyses. All procedures involving use of animals were reviewed and approved by the Institutional Animal Care and Use Committee.
Assay Procedures
11␤HSD dehydrogenase activity. Detailed assay procedures and validation for placental 11␤HSD dehydrogenase were previously published [12] . Enzymatic activity was measured in the presence of saturating substrate (2.5 M unlabeled ϩ 0.86 Ci labeled cortisol) and coenzyme (800 M NAD ϩ ) concentrations. Filtered placental homogenates containing protein concentrations of 450 Ϯ 26 g (mean Ϯ SEM) per 100 l were prepared as described previously [12] . For the current studies, seven assays were conducted that each included one replicate from all treatment groups. The same nonexperimental sample served as an internal standard in each assay and provided an interassay coefficient of variation (CV) of 23.9%. All samples were assayed in triplicate (average CV of triplicate determinations ϭ 5.23%), and specific conversion of [1, 2, 6, H]cortisol (Amersham, Arlington Heights, IL) into labeled cortisone was calculated by subtracting nonspecific conversion in the presence of a heat-denatured placental preparation from total conversion. Each assay was used as a blocking factor in the statistical analysis of enzymatic data. One assay (block) was repeated once, and the average of the two assays for each sample was used in subsequent analyses.
Numerous attempts were made to validate procedures for measurement of 11␤HSD oxoreductase activity in homogenates prepared from frozen tissues. This assay made use of [ 3 H]cortisone and the coenzyme NADPH. Many steps in the validation (linearity with time, 0-30 min; linearity with protein concentration, 230-950 g protein; optimum pH, 6.0) and determination of saturating coenzyme (K m ϭ 18.9 M) concentrations were accomplished. However, repeatability among experimental assays proved to be exceptionally poor, casting doubt on the reliability of the data and, perhaps, reflecting problems that other investigators have experienced using frozen and stored or homogenized tissues [9, 22] . Hence, no data are presented for 11␤HSD oxoreductase activity.
RNA isolation and Northern blot analyses. Total RNA was isolated from tissues using RNeasy Kits (Qiagen, Chatsworth, CA). Placental RNA was loaded onto denaturing MOPS (3-[N-Morpholino] propanesulfonic acid) 1.25% agarose/formaldehyde gels, and electrophoresis was conducted. Subsequently RNA was transferred to nylon membranes (Hybond-N; Amersham) via capillary blotting and was fixed to the membrane using ultraviolet (UV) cross-linking (UV Stratalinker 2400; Stratagene, La Jolla, CA). Porcine cDNA for 11␤HSD-1 was cloned from adult porcine liver, and cDNA for 11␤HSD-2 was cloned from adult kidney. Both cDNAs were obtained by a modified 3Ј-rapid amplification of cDNA ends and cloned into a pBluescript KS vector (Stratagene). Briefly, first-strand cDNAs were synthesized using an oligo-dT-adapter primer (designed in house; 5Ј GTC GAC GGT ACC GAT ATC T17 3Ј) in a total volume of 20 l. An aliquot (2 l) was then subjected to a standard polymerase chain reaction (PCR; 94ЊC, 55 sec; 50ЊC, 55 sec; 72ЊC, 2 min; 30 cycles) by using the adapter primer and a gene-specific primer (5Ј GGG GGG TAC CCG GGT AGA AAG CTC TGT AGG 3Ј) that corresponds to nucleotides 1-20 in the ovine 11␤HSD-1 cDNA [23] and the primer 5Ј CTG AAG CTG CTG CAG ATG GA 3Ј that corresponds to nucleotides 405-424 in the murine 11␤HSD-2 cDNA [24] . These cDNAs were subsequently sequenced, determined to be more than 70% homologous with other mammalian counterparts, and submitted to GenBank (11␤HSD-1, accession no. AF 414124, 1348 base pairs [bp]; 11␤HSD-2, accession number AF 414125, 1304 bp). Shorter cDNAs to be used for Northern blot analyses were generated from these larger cDNAs using, for 11␤HSD-1, the forward-primer 5Ј TTC TGG GGA TCT TCT TGG C 3Ј and the reverse-primer 5Ј AGT GGA TTC GCC ATT TTC C 3Ј and, 11␤HSD-2, the forward-primer 5Ј GCC AGC AGA CAT TAG CCG 3Ј and the reverse-primer 5Ј AAG TAC ATG AGC CCC AGG C 3Ј. These primer pairs generated a cDNA for 11␤HSD-1 that contained a 505-bp fragment that was 88-90% homologous with other species. Primer pairs for 11␤HSD-2 generated a cDNA that contained a 624-bp fragment and was 83-87% homologous with other species. These cDNAs for 11␤HSD-1 and 11␤HSD-2 had no sequence similarity with the other 11␤HSD isoform.
For the porcine GR, total RNA was isolated from female pig liver. Reverse transcription was then conducted as previously described [25] using random nonamer primers (Amersham) to produce cDNA. To amplify the GR, specific cDNA primers were designed for regions of the human GR␣ 3Ј-untranslated region [14] . These primers (forward primer, 5Ј TTG GTG CTT CTA ACC TGA TGG 3Ј; reverse primer, 5Ј GAT GGG AAT GTG AAA ATG GG 3Ј) produced a 491-bp cDNA that would be specific for GR␣ [14] if the porcine GR is comparable to the human GR. This sequence was found to be 89.6% homologous with human GR 9␣ (U80946 and X03225) and was submitted to GenBank (accession no. AY007222). Porcine cDNA for porcine ␤-actin was generated, and cDNA were cloned and sequenced as previously described [25] .
For Northern blot analyses, 32 P-labelled cDNAs were prepared using PCR procedures, [ 32 P]dCTP (Dupont New England Nuclear, Wilmington, DE), and the above-noted primers specific for 11␤HSD and beta-actin transcripts. For Northern blot analyses of GR, and for ␤-actin in the same Northern blot membrane preparations, cRNAs were prepared, and procedures detailed in Ambion's MAXIscript in vitro transcription kit (Ambion, Austin, TX) and [␣-32 P] UTP (Amersham) were used for preparation of 32 P-labelled cRNA probes.
Northern blot analyses using these labeled cDNAs and cRNAs were conducted essentially as previously described for erythropoietin mRNA [25] . To insure that variability among processing operations was evenly distributed across all treatments, RNA from each treatment was equally represented on each gel/membrane, and membranes were used as a blocking factor in statistical analyses. Densitometric measures were conducted with a ChemImager (Alpha Innotech Corp., San Leandro, CA), or with Epi Chemi Darkroom (UVP, Inc., Upland, CA) used in conjunction with the NIH Image program (National Insitutes of Health, Research Services Branch, Bethesda, MD. Website at http://rsb.info.nih.gov/nih image/).
Statistical Analyses
Data for mRNA and enzymatic activity were analyzed using the Statistical Analysis System [26] . All data were examined for normality of distribution (PROC UNIVARIATE NORMAL) and homogeneity of variance (F max test) and were transformed to a log or square root function when necessary to meet assumptions of analysis of variance. Enzymatic activity (mean of replicate analyses for each sample) was then analyzed using PROC MIXED and two-way analysis of covariance (ANOCVA) with treatments and day of gestation as main factors and assay as a random factor. Activity of the internal standard in each assay served as the covariate. All data for mRNA bands of interest were also analyzed using PROC MIXED and two-way ANOCVA with treatments and day of gestation as main factors and gel as a random factor. Each mRNA of interest was adjusted using ANOCVA and expression of ␤-actin in the same lane as a covariate to account for potential differences in lane loading and membrane transfer. Comparisons of individual treatment means were made by a priori orthogonal contrasts. The least-squares mean Ϯ SEM of original data are presented. A probability level of P Յ 0.05 was considered to be significant.
RESULTS
Fetal and placental data for the present study have been reported elsewhere in detail [21] and will not be repeated here. A single band of 11␤HSD-1 mRNA was observed at approximately 1.9 kilobases (kb) (Fig. 1A) . Under conditions of the present study, placental mRNA expression of 11␤HSD-1 was undetectable on Day 24 of gestation (Fig.  1A) , with the exception of one Meishan fetus. Hence, data for Day 24 were not included in the statistical analyses (Fig. FIG. 1. A 1B). The 11␤HSD-1 mRNA expression was modestly present by Day 30 (Fig. 1) . Between Days 30 and 40, a 53% increase (P Ͻ 0.01) was observed in the expression of placental 11␤HSD-1 mRNA in all pig models (Fig. 1 ). No differences (P ϭ 0.45) were observed among the three treatments (pig models).
On the contrary, 11␤HSD-2 mRNA expression was already readily apparent on Day 24 (Fig. 2) . In contrast to 11␤HSD-1, 11␤HSD-2 mRNA had four distinct bands ( Fig.  2A) . A decidedly major band (band A) was present at approximately 2.3 kb, with more minor bands occurring at approximately 1.8, 1.5, and 1.2 kb. Statistical evaluations were conducted on each individual band and on the sum of the densitometric measurements for all bands. Analysis for the major band is presented (Fig. 2B ). For this major band, ANOCVA did not reveal any treatment effects (P ϭ 0.51) or treatment ϫ day interactions (P ϭ 0.10), but it did demonstrate marked day effects (P ϭ 0.01) (Fig. 2B ). These day effects represent an increase in mRNA expression across all treatments on Day 40 compared with Day 30 (P ϭ 0.005). A priori orthogonal contrasts indicate that on Day 30, 11␤HSD-2 mRNA expression is less in WC-UHO pigs than in WC-INT pigs (P ϭ 0.03). When the sum of bands A through D is evaluated, the interpretation of results is the same (data not shown).
Placental 11␤HSD dehydrogenase activity displayed marked, day-dependent increases in activity between Days 30 and 40 of gestation (P ϭ Ͻ 0.01) (Fig. 3) . On Day 24 (using an a priori orthogonal contrast), 11␤HSD dehydrogenase activity in ME placentae was greater than in WC-INT placentae on the same days (P Ͻ 0.037). Although 11␤HSD-2 mRNA and dehydrogenase activity increased in parallel between Days 30 and 40, ANOCVA procedures using 11␤HSD-2 mRNA expression as a covariate did not detect a significant linear relationship between dehydrogenase activity and mRNA expression as measured by the most prominent band or by the sum of all bands (P Ͼ 0.47).
Expression of mRNA for GR was detected in placentae at each stage of gestation (Fig. 4) . Labeled cRNA hybridized with a mRNA of approximately 8.8 kb. An increase (P ϭ 0.013) was observed in GR expression with age that was independent of treatment (P ϭ 0.83) (Fig. 4B ) and that represented a 37% increase (P Ͻ 0.01) between Days 30 and 40. Placental ␤-actin expression was not affected by treatment (P Ͼ 0.22).
DISCUSSION
In the present study, the findings of primary importance are as follows: 1) 11␤HSD-2 mRNA expression and enzymatic activity are present within porcine placentae as early as Day 24 of gestation; 2) placental 11␤HSD-1 mRNA For all species in which detailed studies have been conducted, 11␤HSD-2 functions primarily as a dehydrogenase (converts active cortisol to inactive cortisone) [27] , and 11␤HSD-1, although capable of oxidative and reductive activity, functions primarily as a reductase (converts cortisone to cortisol) [27] . In the present study, we cannot say with certainty that dehydrogenase activity represents only 11␤HSD-2 function. However, the presence of 11␤HSD-2 mRNA expression and assumed (dehydrogenase) biological activity at Day 24, along with the absence of 11␤HSD-1 mRNA expression, suggest an importance for lower active glucocorticoid concentrations in both placentae and embryos. This importance is further suggested by the decline in placental 11␤HSD-2 mRNA expression on Day 30 of gestation in embryos of WC-UHO gilts relative to WC-INT gilts. It was previously shown that decreased embryonic survival occurred in the crowded uterine environment on Day 40 compared with Day 30, although placental weights were not compromised [21] . However, more recent results demonstrated 38% decreases (P ϭ 0.01) in placental weight on Day 35 in WC-UHO gilts [25] .
The cause of decreased 11␤HSD-2 mRNA is unknown. Of the mRNA measured (␤-actin, GR, 11␤HSD-1, and 11␤HSD-2), only 11␤HSD-2 mRNA expression differed between WC-UHO and WC-INT gilts. This suggests a specificity of response in terms of at least these limited numbers of mRNAs. Hence, lower 11␤HSD-2 at Day 30 may be associated with an increased number of compromised embryos that will die by Day 40. Whether altered placental 11␤HSD expression is one cause of subsequent mortality, merely symptomatic of embryonic morbidity, or unrelated to mortality and morbidity, however, remains to be determined. The 11␤HSD dehydrogenase activity was not affected by the crowded uterine environment on Day 30, suggesting different sensitivities of mRNA and active protein to uterine crowding and associated biological alterations. Depending on the half-life of the 11␤HSD-2 protein, reduced mRNA expression would be expected to precede a subsequently lowered activity. An alternative hypothesis would be that 11␤HSD-1 protein is partially contributing to measured dehydrogenase activity in addition to its reductase activity. However, placental 11␤HSD-1 dehydrogenase activity is NADP ϩ -dependent [10, 12, 28] , and in the present assays, NAD ϩ was used as a coenzyme. Furthermore, although intraplacental concentrations of cortisol substrate are not known, plasma cortisol concentrations on Days 16-18 of pregnancy vary from 10 to 38 ng/ml [29] . Embryonic cortisol concentrations on Day 25 are quite low (ϳ1.5 ng/mg DNA, or Ͻ10 ng cortisol/g tissue [17] ). Such cortisol concentrations are incompatible with the previously measured K m of placental NADP ϩ -dependent dehydrogenase activity (849 nM [12] ). It is unlikely, therefore, that placental 11␤HSD-1 provides a substantial contribution to either measured or actual dehydrogenase activity at this stage.
It is also of interest to note the increased placental 11␤HSD dehydrogenase activity in Meishan versus WC-INT gilts. This is additional evidence for differences in aspects of glucocorticoid concentrations or metabolism in Meishan pigs during gestation [30] that could influence fe-tal development and survival. This finding is also contrary to what one might anticipate if glucocorticoids were the primary factor regulating fetal size; that is, with higher placental 11␤HSD-2, one would expect lower fetal cortisol and larger fetal weights [27, 31] . This might be especially true at Day 24, when cortisol impinging on the embryo is predominantly of maternal origin [16, 32] . However, many factors regulate fetal size (e.g., [33, 34] ). Additionally, our interpretation of the potential effects of glucocorticoids on fetal size and the regulation of these effects by placental 11␤HSD and GR are confounded in the present study by an absence of information on embryonic glucocorticoid regulatory mechanisms.
The present study demonstrates the presence in porcine placentae of multiple transcripts of 11␤HSD-2 mRNA expression. The most prominent band occurred at approximately 2.3 kb. In mouse kidney and colon, multiple 11␤HSD-2 mRNA transcripts were evident at approximately 5 and 2.0 kb [24] . In term human placentae, 11␤HSD-2 mRNA was present at 1.9 and 4.0 kb [35] . Hence, precedents exist for multiple 11␤HSD-2 transcripts. However, in other studies, only single transcripts of 11␤HSD-2 mRNA were observed [36] [37] [38] . The biological relevance of these various mRNA species remains to be determined. For example, which bands are translated into active protein is not known, although it might be presumed that the major band (2.3 kb) represents the mRNA that contributes most to active protein. Mechanisms contributing to the various bands may represent alternative cleavage and polyadenylation patterns, alternative splicing of transcripts from a single gene, or transcription from more than one gene. The specific mechanism was not determined, but to date, evidence exists for only one gene encoding 11␤HSD-2 in human tissues [39] .
Expression of 11␤HSD-1 mRNA was almost completely absent in Day 24 placentae with the amount of total RNA (10 g) used. Such absence on Day 24 again suggests an additional mechanism by the developing placenta to minimize exposure of the placenta and embryo to biologically active glucocorticoids, because 11␤HSD-1 may serve to amplify glucocorticoid action at the cellular level [40] .
Day 24 of gestation-relative to term in pigs (114 days; 21% or 0.21 of gestation completed)-represents the earliest measures of placental 11␤HSD mRNA expression in any species. Consequently, it is difficult to compare the relative onset of mRNA expression of these enzymes in pigs with those of other species. However, in human placenta (8-12 wk, or ϳ0.21-0.32 of gestation), there was a 4% conversion of cortisone to cortisol (reductase activity), but a 79% conversion of cortisol to cortisone (dehydrogenase activity [41] ). In baboon placentae at early (0.33) gestation, mRNA and protein expression for both isozymes were present, and both increased with advancing gestation [38] . However, to our knowledge, earlier ages have not been measured. Therefore, the currently reported pattern of initiation of 11␤HSD mRNA expression is most nearly similar to that of enzymatic activities in humans at a comparable age (relative to term). Although, as noted above, data for oxoreductase activity were inconsistent, our measures do indicate the existence of this activity and, thereby, substantiate that translation of this 11␤HSD-1 mRNA into biologically active protein does occur.
We have previously demonstrated that intrauterine cortisol concentrations increase dramatically between Days 10 and 13 of pregnancy in gilts [42] . We have also demonstrated the presence of low cortisol concentrations in porcine embryos at Day 25 of gestation, with an 8-fold increase occurring by Day 35 [16] . Hence, at these early gestational stages in pigs, cortisol is present in the environment and in the embryos themselves, and it has the potential for influencing development. The currently reported early appearance of GR mRNA expression-with the caveat that it is translated into active protein-further suggests the involvement of glucocorticoids in early porcine placental development and/or function and indirectly in embryonic development. It has been previously suggested for other species that the presence of placental 11␤HSD not only reflects a regulation of transplacental passage of glucocorticoids but also a local regulation of placental glucocorticoid actions [43, 44] . Although only minimal indirect evidence exists in pigs [45] , abundant direct and indirect evidence indicates a variety of effects of glucocorticoids on placental function in other species (e.g., [46] [47] [48] ). Therefore, the presence of GR mRNA in the early porcine placenta is consistent with data in other species for a function of cortisol in porcine placentae.
The present study was not designed to evaluate the placental cellular location of either 11␤HSD or GR mRNA expression, as has been done for humans [38, 49, 50] , baboons [49] , and rats [51] . In contrast to hemochorial placentae of rat and humans, the porcine placenta is epitheliochorial in nature. Such a placenta consists of an outer layer of chorionic epithelial cells (trophectoderm) that contact the uterine endometrial epithelium, a somatic mesodermal layer, a splanchnic mesodermal layer, and finally, an inner thin layer of entodermal cells [52] . Hence, our preparations contained all these layers combined, and only by subsequent use of immunohistochemical and in situ hybridization techniques will it be possible to discern the cellular relationships of these enzymatic and receptor regulators of glucocorticoid actions in the porcine placenta. Nonetheless, as has been expressed for other species [44] and tissues [40] , the colocalization of 11␤HSD-1, 11␤HSD-2, and GR in the porcine placenta suggests an intricate regulation of glucocorticoid action in this tissue at these early developmental stages.
In summary, these studies demonstrate the presence of 11␤HSD-1, 11␤HSD-2, and GR mRNA expression as well as 11␤HSD dehydrogenase activity in porcine placentae. Their presence suggests a role for glucocorticoids in porcine placental and embryonic development and function at these early stages of gestation.
